Effectiveness across severe asthma biologic classes (Anti-IL-5 vs Anti IgE) in patients eligible for both (FIRE)

Documents

Study protocol

Initial protocol

ISAR_OPCG1903_Effectiveness across Bx classes_Protocol 13 Aug 2020

Study results

Study report

Other information

ENCePP Seal

The use of the ENCePP Seal has been discontinued since February 2025. The ENCePP Seal fields are retained in the display mode for transparency but are no longer maintained.

Conflicts of interest of investigators

200730_COI_David Price_V8

Composition of steering group and observers

Effectiveness Across Bx Classes_Steering Committee